Enhanced Expression of ANGPTL2 in the Microvascular Lesions of Diabetic Glomerulopathy

Background: Diabetic nephropathy (DN) is one of the most important microvascular complications of diabetes mellitus. However, the underlying mechanisms remain unclear. We studied the expression characteristics of angiopoietin-like 2 (ANGPTL2), a novel DN-associated growth factor identified in our previous gene chip screening. Methods: Glomeruli were microdissected from renal biopsies from 24 patients with DN and 8 donor controls. The expression of ANGPTL2 was assessed by RT-PCR and immunohistochemistry, and then correlated with clinical and pathological indices of glomerular injury. Results: Consistent with the results of the gene chip experiment, abundant expression of ANGPTL2 was found more frequently in diabetic glomeruli as compared to donor controls (95 vs. 38%, χ2 = 15.9, p < 0.01). ANGPTL2 mRNA upregulation was more prominent in glomeruli with less microaneurysm (22 vs. 66%, p < 0.05), inflammatory influx (6 vs. 50%, p < 0.05) or endothelial foam cell formation (11 vs. 53%, p < 0.05). Immunostaining revealed an upregulation of ANGPTL2 protein in hypertrophied diabetic glomeruli, mainly distributed in podocytes, which were supposed to be the origin of ANGPTL2. Conclusion: The upregulation of ANGPTL2 in diabetic glomerulopathy shows a close relationship to abnormal microvasculature and endothelial inflammation. ANGPTL2 may play an important role in the pathogenesis of diabetic glomerulopathy.

[1]  G. Bakris,et al.  The pathogenesis of diabetic nephropathy , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[2]  A. Flyvbjerg,et al.  From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. , 2004, Endocrine reviews.

[3]  M. Goligorsky,et al.  Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. , 2004, Kidney international.

[4]  D. Cha,et al.  Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. , 2004, The Journal of endocrinology.

[5]  T. Berl,et al.  Pathogenesis of Diabetic Nephropathy , 2004, Reviews in Endocrine and Metabolic Disorders.

[6]  H. Sugiyama,et al.  Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. , 2004, Diabetes.

[7]  Ashutosh Kumar Singh,et al.  Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix , 2004, Laboratory Investigation.

[8]  S. Satchell,et al.  Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. , 2004, Journal of the American Society of Nephrology : JASN.

[9]  C. Roussos,et al.  Angiopoietin‐1 inhibits endothelial permeability, neutrophil adherence and IL‐8 production , 2003, British journal of pharmacology.

[10]  S. Satchell,et al.  Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology. , 2003, Journal of nephrology.

[11]  S. Bursell,et al.  Suppression of diabetic retinopathy with angiopoietin-1. , 2002, The American journal of pathology.

[12]  S. Harper,et al.  Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. , 2002, Journal of the American Society of Nephrology : JASN.

[13]  M. V. Shestakov,et al.  [Endothelial dysfunction in the development of vascular complications in diabetes mellitus]. , 2001, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova.

[14]  A. Woolf,et al.  Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development , 2001, Pediatric Nephrology.

[15]  Sybill Patan,et al.  Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling , 2000, Journal of Neuro-Oncology.

[16]  G. Koh,et al.  Molecular Cloning, Expression, and Characterization of Angiopoietin-related Protein , 1999, The Journal of Biological Chemistry.

[17]  E. Cagliero,et al.  Pathobiology of Endothelial and Other Vascular Cells in Diabetes Mellitus: Call for Data , 1991, Diabetes.

[18]  L. Leishi.  Glomerular gene expression profiles in patients with diabetic nephropathy , 2004 .

[19]  L. Leishi.  Altered expression of vascular endothelial growth factor and its receptor in the kidneys of patients with type 2 diabetic nephropathy , 2001 .